Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

UCN-01 and Topotecan in Treating Patients With Recurrent, Persistent, or Progressive Advanced Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer

This study has been completed.
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University Health Network, Toronto Identifier:
First received: November 4, 2003
Last updated: July 22, 2015
Last verified: July 2015
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: April 2005 (Final data collection date for primary outcome measure)